Source - LSE Regulatory
RNS Number : 6576S
Creo Medical Group PLC
13 March 2023
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

 


 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

CREO MEDICAL GROUP PLC

 

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

 

Non-UK issuer


 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

 

An acquisition or disposal of voting rights

X

 

An acquisition or disposal of financial instruments


 

An event changing the breakdown of voting rights

X

 

Other (please specify) iii:


 

3. Details of person subject to the notification obligation iv

 

Name

CANACCORD GENUITY GROUP INC

 

City and country of registered office (if applicable)

VANCOUVER, CANADA

 

4. Full name of shareholder(s) (if different from 3.) v

 

Name

DISCRETIONARY CLIENTS

 

City and country of registered office (if applicable)

As above

 

5. Date on which the threshold was crossed or reached vi:

09 MARCH 2023

 

6. Date on which issuer notified (DD/MM/YYYY):

10 MARCH 2023

 

7. Total positions of person(s) subject to the notification obligation

 


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

 

Resulting situation on the date on which threshold was crossed or reached

12.8167


12.8167

44,972,705

 

Position of previous notification (if

applicable)

13.9990


13.9990


 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

 

A: Voting rights attached to shares

 

Class/type of
shares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

 

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

 

GB00BZ1BLL44


44,972,705


12.8167

 






 






 

SUBTOTAL 8. A

44,972,705

12.8167

 

 

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

 

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 






 






 






 



SUBTOTAL 8. B 1



 

 

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

 

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 







 







 







 



 

SUBTOTAL 8.B.2



 



 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii


Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)
xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Canaccord Genuity Group Inc.

12.8167


12.8167

Canaccord Genuity Wealth Group Holdings Limited

12.8167


12.8167

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

12.8167


12.8167

Canaccord Genuity Wealth Group Limited

12.8167


12.8167

Punter Southall Wealth Limited

0.0009


0.0009

Canaccord Genuity Wealth Limited

0.0064


0.0064

Hargreave Hale Ltd

12.8094


12.8094

 

10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held


The date until which the voting rights will be held


 

11. Additional informationxvi

The change in the percentage of shares held is due mainly to participation in the placing and open offer by Creo Medical Group plc, the shares from which were admitted to AIM on 09/03/2023.

 

Place of completion

BLACKPOOL, ENGLAND

Date of completion

10 MARCH 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAXDFFDADEFA
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Creo Medical Group PLC (CREO)

-0.50p (-1.47%)
delayed 16:30PM